RecruitingNot ApplicableNCT06259916

Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)

Developing Predictive Models to Distinguish Alcohol Use, Cannabis Use and Co-use: An Exploration of Electroencephalography (EEG) Metrics and Traditional Intoxication Measures


Sponsor

Colorado State University

Enrollment

99 participants

Start Date

Jan 5, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a randomized, parallel-group study designed to explore the differences between cannabis intoxication, alcohol intoxication and co-intoxication involving both alcohol and cannabis, utilizing electroencephalography (EEG) as well as more traditional intoxication measures such as breath alcohol concentration and balance metrics. If eligible for the study, participants will be randomized to complete one study session in our mobile laboratory, during which they will use either alcohol, cannabis (which will be self-administered, ad libitum) or both alcohol and cannabis.


Eligibility

Min Age: 21 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Alcohol and Cannabis for people with alcohol use, unspecified and cannabis use. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERAlcohol

Participants in this condition will receive the standard alcohol dose

OTHERCannabis

Participants in this group will self-administer legal-market flower cannabis


Locations(1)

Colorado State University

Fort Collins, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06259916


Related Trials